HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Masayuki Iwano Selected Research

Glomerulonephritis

12/2021Development of Myeloperoxidase Anti-neutrophil Cytoplasmic Antibody-positive Necrotizing Crescentic Glomerulonephritis in an Elderly Patient with Immunological Kidney Disease.
1/2019Elevated Levels of Urinary Extracellular Vesicle Fibroblast-Specific Protein 1 in Patients with Active Crescentic Glomerulonephritis.
5/2016A case of synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome complicated by IgA nephropathy with nephrotic syndrome.
1/2005All-trans-retinoic acid inhibits the development of mesangial proliferative glomerulonephritis in interleukin-6 transgenic mice.
4/2002Expression of glomerular plasminogen activator inhibitor type 1 in glomerulonephritis.
1/2002In vitro effects of Habu snake venom on cultured mesangial cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Masayuki Iwano Research Topics

Disease

11Fibrosis (Cirrhosis)
01/2020 - 08/2002
9Proteinuria
06/2022 - 04/2002
6Glomerulonephritis
12/2021 - 01/2002
6Chronic Renal Insufficiency
08/2020 - 12/2007
5Kidney Diseases (Kidney Disease)
01/2022 - 11/2014
5Inflammation (Inflammations)
01/2020 - 04/2014
4Interstitial Nephritis (Tubulointerstitial Nephritis)
10/2021 - 12/2017
4Renal Insufficiency (Renal Failure)
01/2021 - 12/2009
4Lupus Nephritis
09/2014 - 07/2007
4IGA Glomerulonephritis (IGA Nephropathy)
03/2012 - 08/2002
3Nephrotic Syndrome (Syndrome, Nephrotic)
06/2022 - 10/2014
3Membranous Glomerulonephritis (Membranous Nephropathy)
06/2022 - 10/2014
3Type 2 Diabetes Mellitus (MODY)
01/2021 - 03/2016
3Chronic Kidney Failure (Chronic Renal Failure)
01/2021 - 01/2018
3Hypoxia (Hypoxemia)
10/2020 - 05/2008
3Hepatocellular Carcinoma (Hepatoma)
01/2020 - 07/2018
3Atherosclerosis
11/2015 - 12/2009
3Hematuria
01/2012 - 01/2005
2Starvation
07/2022 - 06/2021
2Fanconi Syndrome (Syndrome, Fanconi)
06/2022 - 12/2017
2Disease Progression
06/2022 - 08/2002
2Infections
12/2021 - 01/2006
2Myocardial Infarction
08/2020 - 08/2014
2IgA Vasculitis (Purpura, Schoenlein Henoch)
03/2020 - 01/2012
2Neoplasms (Cancer)
01/2020 - 10/2008
2Diabetic Nephropathies (Diabetic Nephropathy)
01/2018 - 03/2012
2Anemia
10/2017 - 11/2015
2Fever (Fevers)
05/2016 - 03/2012
2Body Weight (Weight, Body)
05/2016 - 10/2014
2Wilms Tumor (Wilm's Tumor)
05/2015 - 06/2012
1Autoimmune Diseases (Autoimmune Disease)
06/2022
1Hypophosphatemia
06/2022
1Hypokalemia
06/2022
1Heavy Metal Poisoning
06/2022
1Acidosis
06/2022
1Sarcoidosis (Schaumann Disease)
12/2021
1Hypercalcemia (Milk Alkali Syndrome)
12/2021
1Albuminuria
01/2021
1Microaneurysm
10/2020
1Acute Kidney Injury (Acute Renal Failure)
08/2020
1Rheumatoid Arthritis
03/2020
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2020

Drug/Important Bio-Agent (IBA)

10CreatinineIBA
01/2021 - 08/2002
5Prednisolone (Predate)FDA LinkGeneric
06/2022 - 01/2012
5Immunoglobulin M (IgM)IBA
10/2021 - 09/2014
5CytokinesIBA
01/2020 - 03/2002
5Messenger RNA (mRNA)IBA
03/2012 - 01/2002
4Biomarkers (Surrogate Marker)IBA
01/2021 - 12/2014
3Immunoglobulin G (IgG)IBA
12/2021 - 04/2002
3Cisplatin (Platino)FDA LinkGeneric
06/2021 - 07/2018
3AlbuminsIBA
01/2021 - 12/2013
3podocalyxinIBA
10/2020 - 06/2012
3S100 Calcium-Binding Protein A4IBA
01/2019 - 10/2008
3SteroidsIBA
12/2017 - 10/2014
3AntibodiesIBA
12/2017 - 09/2014
3Phosphates (Orthophosphate)IBA
11/2015 - 01/2014
3Proteins (Proteins, Gene)FDA Link
12/2014 - 09/2005
3Transforming Growth Factor beta (TGF-beta)IBA
01/2010 - 05/2004
3Interleukin-6 (Interleukin 6)IBA
01/2005 - 03/2002
2mizoribineIBA
06/2022 - 12/2017
2Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
12/2021 - 01/2006
2TinIBA
10/2021 - 01/2021
2GlucocorticoidsIBA
10/2021 - 05/2016
2Adrenal Cortex Hormones (Corticosteroids)IBA
01/2021 - 10/2008
2ThioredoxinsIBA
08/2020 - 12/2014
2EnzymesIBA
08/2020 - 01/2020
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2020 - 03/2002
2Streptozocin (Streptozotocin)FDA Link
01/2020 - 03/2012
2G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
01/2020 - 01/2017
2PropionatesIBA
01/2020 - 07/2018
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
11/2015 - 12/2009
2VimentinIBA
05/2015 - 06/2012
2E-SelectinIBA
09/2014 - 10/2013
2ApolipoproteinsIBA
02/2014 - 12/2009
2Tyrosine (L-Tyrosine)FDA Link
02/2014 - 12/2009
2Ligases (Synthetase)IBA
06/2009 - 10/2008
2UbiquitinIBA
06/2009 - 10/2008
2Biological ProductsIBA
05/2008 - 01/2002
1Fenofibrate (CiL)FDA LinkGeneric
07/2022
1Immunosuppressive Agents (Immunosuppressants)IBA
06/2022
1Oxidoreductases (Dehydrogenase)IBA
06/2022
1Anticonvulsants (Antiepileptic Drugs)IBA
06/2022
1Antiviral Agents (Antivirals)IBA
06/2022
1Inosine Monophosphate (IMP)IBA
06/2022
1Rituximab (Mabthera)FDA Link
06/2022
1Peroxidase (Myeloperoxidase)IBA
12/2021
1ParaproteinsIBA
10/2021
1Immunoglobulins (Immunoglobulin)IBA
10/2021
1(4- (((2- (3- fluoro- 4- (trifluoromethyl)phenyl)- 4- methyl- 1,3- thiazol- 5- yl)methyl)sulfanyl)- 2- methylphenoxy)acetic acidIBA
06/2021
1Glucose (Dextrose)FDA LinkGeneric
10/2020
1Pharmaceutical PreparationsIBA
03/2020
1tofacitinibIBA
03/2020
1Nonesterified Fatty Acids (NEFA)IBA
01/2020

Therapy/Procedure

8Therapeutics
01/2022 - 12/2009
2Transplantation
08/2014 - 07/2010
1Kidney Transplantation
06/2022
1Oral Administration
06/2022
1Intravenous Injections
06/2022
1Precision Medicine
01/2022
1Drug Therapy (Chemotherapy)
01/2020